Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 8 Issue 4

Some Important Markers of Osteoporosis in Women in Menopause

Zaripova Dilnoza Yashinovna*, Fayziyev Yusuf Kadirovich and Rustamova Umida Mukhtarovna

Department of Obstetrics and Gynecology No. 2, Bukhara Medical Institute Named After Abu Ali ibn Sino, Bukhara Regional Perinatal Center, Uzbekistan

*Corresponding Author: Zaripova Dilnoza Yashinovna, Department of Obstetrics and Gynecology No. 2, Bukhara Medical Institute Named After Abu Ali ibn Sino, Bukhara Regional Perinatal Center, Uzbekistan.

Received: November 16, 2023; Published: March 20, 2024

Abstract

Osteoporosis is a skeletal disease characterized by low bone mass, structural destruction of bone tissue and reduced bone strength, resulting in increased the risk of fractures [1,2,9]. It is one of the most common metabolic diseases and the main cause of morbidity and mortality among postmenopausal women [3,10]. Previous studies have shown that several conditions such as aging, amenorrhea, parental history of fractures, [4,5] dietary calcium intake, low body mass index (BMI) [6-8], decreased physical activity have been suggested as associated factors in changes in bone mineral density in elderly patients.

 Keywords: Osteoporosis; Bone Mineral Density; Bone Resorption; Osteodensitometry

References

  1. Dedov II., et al. “The role and place of bisphosphonates in the prevention and treatment of osteoporosis”. Journal of Osteoporosis and Osteopenia 1 (2005): 20-30.
  2. Zaripova DYa., et al. “The role of Aleandronic acid (Ostalon) in the treatment of perimenopausal osteoporosis”. Ahborotnomasi 4.3 (2019): 23-27.
  3. Zaripova DYa., et al. “Influence of magnesium deficiency state and imbalance of steroid hormones on the vital activity of a woman's body. Tibbiyotda Yangi Kun 3-27 (2019): 14-17.
  4. Zaripova Dya and Tuksanova DI. “Experience of using the transdermal drug Lenzetto in perimenopausal women with concomitant diseases”. A New Day in Medicine 2.30/2 (2020): 286.
  5. Negmatullaeva MN., et al. “The use of different administration of the route of estrogen-containing drugs in women of climacteric age”. Tibbiyotda Yangi Kun 3.31 (2020): 413-416.
  6. Khatamova MT and Solieva NK. “Actual features of chronic pyelonephritis in women of childbearing age”. New Day of Medicine 3.27 (2019): 278-281.
  7. Tuksanova DI and Zaripova DYa. “The modern important ways diagnosis of postmenopausal osteoporosis”. Tibbiyotda yangi kun 4.34 (2020): 416-418.
  8. Zaripova Dya and Tuksanova DI. “Diagnosis of osteoporosis in women in menopause”. Biology Wa Tibbiyot Muammolari1 (2021): 107-108.
  9. Sharipova RG and Zaripova DYa. “Effectiveness of using aleandronic acid with hormone replacement therapy alone and together”. Tibbiyotda Yangi Kun 3.31 (2020): 538-541.
  10. Zaripova D and Sharipova R. “Comparative evaluation of the use of aleandronic acid in menopausal women complicated by osteoporosis”. European Journal of Biomedical and Pharmaceutical Sciences 7.6 (2020): 145-147.

Citation

Citation: Zaripova Dilnoza Yashinovna., et al. “Some Important Markers of Osteoporosis in Women in Menopause”.Acta Scientific Medical Sciences 8.4 (2024): 49-51.

Copyright

Copyright: © 2024 Zaripova Dilnoza Yashinovna., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US